Lilly Settles Zyprexa Claims With South Carolina
Bloomberg is reporting this morning that Eli Lilly has reached a tentative settlement with the State of South Carolina over allegations that the company illegally marketed Zyprexa, the company’s atypical antipsychotic, for unapproved uses. The state’s lawsuit against Lilly had been set to go to trial this week, but Lilly won a delay and then hammered out an agreement with the state. Financial details of the settlement are not yet available.
Related posts: